FOR U.S. HEALTHCARE PROFESSIONALS

ABBVIE MEDICAL AFFAIRS

The Fight Against HCV

In 2013, viral hepatitis was a leading cause of death worldwide. More than 90% of this burden is due to the hepatitis B virus (HBV) and hepatitis C virus (HCV).1

The 2014 World Health Assembly asked the World Health Organization (WHO) to explore how to eliminate HCV. In response, the WHO set 2030 targets for diagnosis, treatment, incidence, and mortality that would achieve the goal of eliminating HCV as a global health burden. Below are more details about the mission—as well as how we all can help make this important mission a reality.

Treater landscape is changing

  • The paradigm is shifting toward more nonspecialist providers treating HCV2
  • Remote specialist oversight could mean more patients treated by primary care providers, with fewer specialist resources used3


The HCV landscape has changed

The HCV landscape has changed.

The WHO report on eliminating hepatitis C

The WHO report on eliminating hepatitis C.

MappingHepC.com

MappingHepC.com shows you where patients are located and provides characteristics of diagnosed RNA+ patients.

HCV and the opioid crisis

HCV and injection drug use.

Find a syringe exchange program near you

Find a syringe exchange program near you.

Working with the CDC to start a syringe services program

Working with the CDC to start a syringe services program.